Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva
Clinical Pharmacokinetics · 2026-05 · 65 (5) · 719-730
DOI: 10.1007/s40262-026-01626-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 17.03.2026. Verfasst von Thi A Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Pharmacy School, Faculty of Medicine and Health, Pharmacy Building (A15), The University of Sydney, Sydney, NSW, 2006, Australia. Hauptthemen laut MEDLINE: Saliva, Tuberculosis, Multidrug-Resistant, Linezolid, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council, National Foundation for Science and Technology Development, The University of Sydney.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Therapeutic drug monitoring (TDM) of linezolid for treating multidrug-resistant tuberculosis (MDR-TB) is recommended but is hindered by the invasive and logistical challenges of plasma sampling. Saliva is a promising alternative, but a saliva pharmacokinetic model to inform dosing is lacking. This study aimed to develop a saliva-based population pharmacokinetic (popPK) model and evaluate limited sampling strategies for linezolid in MDR-TB. METHODS: Plasma and saliva samples were collected at pre-dose, 2-, and 5-h post-dose from adults treated with linezolid for ≥ 7 days. A saliva-plasma popPK model was developed in NONMEM with covariate analysis. Bayesian estimation and Monte Carlo simulations were used to evaluate the predictive performance of saliva limited sampling strategies for predicting plasma AUC0-24. A ±20% bias versus reference was considered acceptable. RESULTS: One-compartment plasma model incorporating a saliva hypothetical effect compartment with first-order absorption and elimination best described the data (102 paired saliva-plasma samples, 17 patients). Body weight influenced volume of distribution with an exponent of 1.1 (95% CI 1.01-1.18). The three-sample (pre-dose, 2-, and 5-h) saliva strategy adequately predicted plasma AUC0-24 with < 5% median bias. A single saliva sample at pre-dose or 2 h post-dose provided accurate plasma AUC0-24 predictions (< 5% median bias). CONCLUSIONS: The validated model enables reliable estimation of plasma AUC0-24 using limited saliva samples. A single saliva sample (pre-dose or 2 h post-dose) can accurately predict plasma AUC0-24, supporting saliva-based TDM as a practical alternative to plasma-based monitoring of linezolid in MDR-TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sydney Pharmacy School, Faculty of Medicine and Health, Pharmacy Building (A15), The University of Sydney, Sydney, NSW, 2006, Australia.
- Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia.
- Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia.
- Ho Chi Minh City University of Technology, Ho Chi Minh City, Vietnam.
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
- Woolcock Institute of Medical Research, Hanoi, Vietnam.
ORCID-Profile: Thi A Nguyen, Tri P Nguyen, Hoa D Vu, Greg J Fox, Jan-Willem C Alffenaar, Sophie L Stocker
Förderung
- National Health and Medical Research Council
- National Foundation for Science and Technology Development
- The University of Sydney
Zitieren
APA
Nguyen, T. A., Nguyen, T. P., Nguyen, A. T., Dinh, L. V., Nguyen, H. B., Vu, H. D., Nguyen, T. N. B., Vu, D., Fox, G. J., Alffenaar, J. C., & Stocker, S. L. (2026). Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva. Clinical Pharmacokinetics, 65(5), 719-730. https://doi.org/10.1007/s40262-026-01626-4
Vancouver
Nguyen TA, Nguyen TP, Nguyen AT, Dinh LV, Nguyen HB, Vu HD, et al. Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva. Clinical Pharmacokinetics. 2026;65(5):719-730. doi:10.1007/s40262-026-01626-4
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thi A and Nguyen, Tri P and Nguyen, Anh T and Dinh, Luong V and Nguyen, Hoa B and Vu, Hoa D and Nguyen, Tram N B and Vu, Dang and Fox, Greg J and Alffenaar, Jan-Willem C and Stocker, Sophie L},
title = {Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva},
journal = {Clinical Pharmacokinetics},
year = {2026},
volume = {65},
number = {5},
pages = {719--730},
doi = {10.1007/s40262-026-01626-4}
}
EUVIMED